Nancy Benovich Gilby Named Ripple Science’s Chief Technology Officer
University of Michigan SaaS technology startup expands team
ANN ARBOR, Michigan – October 29, 2018 – Ripple Science Corporation announces Nancy Benovich Gilby as the company’s chief technology officer. Nancy joins Ripple Science at a pivotal juncture, as the company wraps up new capital fundraising and turns its focus to refining and expanding its product offering.
“I am passionate about pursuing innovation and solving problems that make a difference” shared Benovich Gilby. At a time when the company has strong market validation with more than $100K in ARR from over 70 customers in North America and the EU, Nancy lends expertise and experience in focusing the product development for Ripple’s target user. “I work in areas with ‘big ideas’ many of which are the first of their kind. That potential drew me to Ripple’s enthusiastic team and the space they are creating. The more I learned the more I knew this was a great company with a great product, that I could add value to.”
Nancy Benovich Gilby has extensive experience in building successful startups. She has helped raise twelve rounds of venture capital funding and has developed a unique, integrated approach for company and engineer development. Her leadership in product strategy and development has contributed to the successful exit of eight high tech startups and the launch of twelve new market products, including MarketSoft (purchased by Unica, IBM), Firefly (purchased by Microsoft), Wildfire (purchased by Orange) and Component Software (purchased by Sun, precursor to Java). She holds an MSE and a BSE from the University of Michigan.
“Nancy joins me in bringing Silicon Valley experience to southeast Michigan. Ripple Science plans to disrupt the $71 billion pharma research industry with its suite of cloud-based products that address the two biggest problems faced when conducting clinical trials, patient recruitment and patient retention, and Nancy is the right technical lead to ensure our solution is robust, scalable and customer-centered,” stated Peter Falzon, President and CEO of Ripple Science.
About Ripple Science
Launched in 2017, Ripple Science is a technology startup focused on transforming the research experience for clinical, translational, and usability testing researchers and participants. Our first product, Ripple SaaS, is a HIPAA-compliant web tool that facilitates the recruitment and management of research participants for translational and clinical studies. Ripple SaaS accelerates the entire research lifecycle by adopting marketing innovations (workflows, automation, analytics) that help teams increase the recruitment and retention of research participants, save time and resources, and reduce risks due to under-enrollment. Our software is currently being used by research investigators in some of the most prestigious universities in the USA, Canada, the UK, and the European Union.